Case Study

Metabolomics uncovers time-dependent metabolic responses to exercise

In collaboration with Metabolon, leading researchers reveal dynamic metabolic responses across key tissues that are modulated depending on timing of exercise.

A recent study published in Cell Metabolism used Metabolon’s Global Discovery Panel to characterize the metabolic responses to exercise timing in nine different tissue types collected from mice. They identified several key metabolites associated with both active and rest periods. These results are a starting point for a unraveling the relationship between exercise and energy homeostasis and how disrupted relationships are linked to metabolic disease.

A recent study published in Cell Metabolism used Metabolon’s Global Discovery Panel to characterize the metabolic responses to exercise timing in nine different tissue types collected from mice. They identified several key metabolites associated with both active and rest periods. These results are a starting point for a unraveling the relationship between exercise and energy homeostasis and how disrupted relationships are linked to metabolic disease.

Metabolomics uncovers time-dependent metabolic responses to exercise

The Challenge

Circadian rhythms are critical for maintaining metabolic homeostasis, and disruption of circadian alignment can lead to metabolic diseases. Timing of food intake can change circadian coordination of metabolic responses and subsequent disease progression. Similarly, temporal control of exercise can also impact energy homeostasis and metabolic pathways relevant for glycemic control and weight loss. However, the optimal timing of exercise required to generate desired metabolic outcomes across various tissues remains unclear. To tackle this challenge, Metabolon helped scientists uncover and map global metabolite responses to exercise across tissues associated with metabolic health1.

The Metabolon Insight

To understand how exercise timing impacts tissue and systemic metabolism, scientists compared samples obtained from mice that performed for one hour on a treadmill when they typically sleep (rest phase) or are typically awake (active phase), as well as sedentary controls. Comprehensive sample collection included serum, skeletal muscle, liver, heart, hypothalamus (HT), epididymal white adipose tissue (eWAT), inguinal white adipose tissue (iWAT), and interscapular brown adipose tissue (BAT) sample for metabolomics analysis.

Using untargeted metabolomics, scientists identified 600-900 metabolites in each tissue type including ~550-800 annotated metabolites. Further analyses of these data not only revealed differences in exercise time and group (exercise vs. sedentary), but also unique metabolic responses depending on the time of day exercise was performed. For example, exercise during the active phase altered more muscle, serum, heart, HT, iWAT, and BAT metabolites compared to the rest phase. Moreover, altered metabolites exhibit time-dependent dissociations – eWAT metabolites generally decreased with exercise in the rest phase, but increased during the active phase.

Metabolomics reveals time and tissue-dependent responses to exercise.

Figure 1: Metabolomics reveals time and tissue-dependent responses to exercise.

With a global metabolomic profile, scientists were able to dissect these data into metabolite classes. Interestingly, amino acids (AA) and lipids were more impacted by exercise during the active phase, but these changes were also dependent on tissue type. For example, fatty acid and glycerol metabolites accumulated in the liver following exercise during the rest phase while the same metabolites accumulated in serum and iWAT following active phase exercise. A number of other metabolites (e.g. corticosterone, glycogens, nucleotides, carbohydrates) also exhibited tissue and time-dependent effects of exercise.

Applying Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis to their dataset, the scientist found robust time-of-day effects of exercise on pathway molecules associated with nucleotides (e.g. purine, pyrimidine), AAs (e.g. glycine, serine, and threonine) or fatty acids (e.g. unsaturated fatty acid biosynthesis metabolites). Moreover, pair-wise metabolite correlations revealed strong time-dependent crosstalk between muscle and liver, with particularly strong effects during active phase exercise. Their map of exercise metabolism also provided improved mechanistic insight into exerkines (signaling metabolites that respond to exercise) such as 2-hydroxybutyrate (2-HB), which exhibits dynamic fluctuations depending on time of day and is robustly modulated by exercise during the active phase.

Exerkines such as 2-HB exhibit temporal responses to circadian rhythms and are modulated by exercise time.

Figure 2: Exerkines such as 2-HB exhibit temporal responses to circadian rhythms and are modulated by exercise time.

The Value of Discovery

By leveraging the insights provided by global untargeted metabolomics data, scientists have gained greater clarity and context on energy homeostasis. Given the sensitivity of metabolic responses to circadian rhythms, the research presented here reveals an “atlas of exercise metabolism” that is robustly impacted by the time of day. Together, these scientists compiled an important resource that serves as a starting point for a comprehensive understanding of a variety of signaling metabolites linked to metabolic diseases and uncovers mechanistic insights toward optimizing the benefits of exercise.

References

1. Sato, S., Dyar, K.A., Treebak, J.T., Jepsen, S.L., Ehrlich, A.M., Ashcroft, S.P., Trost, K., Kunzke, T., Prade, V.M., Small, L., et al. (2022). Atlas of exercise metabolism reveals time-dependent signatures of metabolic homeostasis. Cell Metab 34, 329-345 e328. 10.1016/j.cmet.2021.12.016.

References

1. Zgoda-Pols, J.R., et al., Metabolomics analysis reveals elevation of 3-indoxyl sulfate in plasma and brain during chemically-induced acute kidney injury in mice: investigation of nicotinic acid receptor agonists. Toxicol Appl Pharmacol, 2011. 255(1): p. 48-56.

2. Bryant, J.A., et al., The impact of an oral purified microbiome therapeutic on the gastrointestinal microbiome. Nat Med, 2026. 32(1): p. 186-196

3. McGovern, B .H., et al., SER-109, an Investigational Microbiome Drugto Reduce Recurrence After Clostridioides difficile Infection: Lessons Learned From a Phase 2 Trial. Clin Infect Dis, 2021. 72(12): p. 2132-2140.

4. Feuerstadt, P., et al., SER-109, an Oral Microbiome Therapy for Recurrent Clostridioides difficile Infection. N Engl J Med, 2022. 386(3): p. 220-229.

5. Hu, Z., et al., Targeted metabolomics reveals novel diagnostic biomarkers for colorectal cancer. Mol Oncol, 2025. 19(6): p. 1737-1750.

6. Butler, F.M., et al., Vegetarian Dietary Patterns and Diet-Related Metabolites Are Associated With Kidney Function in the Adventist Health Study-2 Cohort. J Ren Nutr, 2025.

7. Stanford, J., et al., Metabolomic Profiling and Diet Quality Scoring in a Randomized Crossover Trial of Healthy and Typical Dietary Patterns. Mol Nutr Food Res, 2025 . 69(23): p. e70271.

8. O’Connor, L.E., et al., Metabolomic Profiling of an Ultraprocessed Dietary Pattern in a Domiciled Randomized Controlled Crossover Feeding Trial. J Nutr, 2023. 153(8): p. 2181-2192.

9. Fritsch, D.A., et al., Microbiome function underpins the efficacy of a fiber-supplemented dietary intervention in dogs with chronic large bowel diarrhea. BMC Vet Res, 2022. 18(1): p. 245.

10. Leal, L.N., et al., Preweaning nutrient supply improves lactation productivity and reduces the risk of culling in Holstein cows. J Dairy Sci, 2025. 108(6): p. 5875-5888.

11. Ahsin, M., et al., Soil and pasture health underlie improved beef nutrient density determined by untargeted metabolomics in Southern US grass finished beef systems. NPJ Sci Food, 2025. 9(1): p. 151.

12. Yin, W., et al., Plasma lipid profiling across species for the identification of optimal animal models of human dyslipidemia. J Lipid Res, 2012. 53(1): p. 51-65.

13. Porter, F .D., et al., Cholesterol oxidation products are sensitive and specific blood-based biomarkers for Niemann-Pick C1 disease. Sci Transl Med, 2010. 2(56): p. 56ra81.

14. Needham, B .D., et al., Plasma and Fecal Metabolite Profiles in Autism Spectrum Disorder. Biol Psychiatry, 2021. 89(5): p. 451-462

15. Li, C., et al., Estradiol and mTORC2 cooperate to enhance prostaglandin biosynthesis and tumorigenesis in TSC2-deficient LAM cells. J Exp Med, 2014. 211(1): p. 15-28.

16. Green, P.G., et al., Metabolic flexibility and reverse remodelling of the failing human heart. Eur Heart J, 2025. 46(25): p. 2422-2433.

17. Maekawa, H., et al., SGLT2 inhibition protects kidney function by SAM-dependent epigenetic repression of inflammatory genes under metabolic stress. J Clin Invest, 2025. 135(19).

18. Wu, D., et al., Integrated screens reveal that guanine nucleotide depletion, which is irreversible via targeting IMPDH2, inhibits pancreatic cancer and potentiates KRAS inhibition. Gut, 2026.

19. Schwerdtfeger, L.A., et al., Gut microbiota and metabolites are linked to disease progression in multiple sclerosis. Cell Rep Med, 2025. 6(4): p. 102055.

20. Wu, H., et al., Microbiome-metabolome dynamics associated with impaired glucose control and responses to lifestyle changes. Nat Med, 2025. 31(7): p. 2222-2231.

21. Jacobs, J.P., et al., Cognitive behavioral therapy for irritable bowel syndrome induces bidirectional alterations in the brain-gut-microbiome axis associated with gastrointestinal symptom improvement. Microbiome, 2021. 9(1): p. 236.

22. Pietzner, M., et al., Plasma metabolites to profile pathways in noncommunicable disease multimorbidity. Nat Med, 2021. 27(3): p. 471-479.

23. Faquih, T.O., et al., Robust Metabolomic Age Prediction Based on a Wide Selection of Metabolites. J Gerontol A Biol Sci Med Sci, 2025. 80(3).

24. Scherer, N., et al., Coupling metabolomics and exome sequencing reveals graded effects of rare damaging heterozygous variants on gene function and human traits. Nat Genet, 2025. 57(1): p. 193-205.

25. Holmes, Z.C., et al., Untargeted metabolomic analysis of human milk from healthy mothers reveals drivers of metabolite variability. Sci Rep, 2024. 14(1): p. 20827.

26. Titz, B., et al., Implications of Ocular Confounding Factors for Aqueous Humor Proteomic and Metabolomic Analyses in Retinal Diseases. Transl Vis Sci Technol, 2024. 13(6): p. 17.

27. Bloom, S.M., et al., Cysteine dependence of Lactobacillus iners is a potential therapeutic target for vaginal microbiota modulation. Nat Microbiol, 2022. 7(3): p. 434-450.

28. Leimer, E.M., et al., Lipid profile of human synovial fluid following intra-articular ankle fracture. J Orthop Res, 2017. 35(3): p. 657-666.